EV/EBITDA
10.95
-1.63-12.96%
Wed, 05 Mar 2025 23:03:28 GMT
Summary
- As of March 6, 2025, SPRO EV/EBITDA is 10.95, with a fall of -1.63 (-12.96%) during the most recent trading day.
- Over the past year, SPRO EV/EBITDA has increased by +10.26 (+1486.96%).
- SPRO EV/EBITDA is now -12.96% below its all-time high of 12.58.
Performance
SPRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -13.0% | +12.9% | +9.7% |
| 1 m1 month | +12.3% | -12.3% | -6.2% |
| 3 m3 months | +240.1% | -239.9% | -29.6% |
| 6 m6 months | +1360.0% | -301.5% | -38.1% |
| ytdytd | +61.3% | -61.4% | -18.5% |
| 1 y1 year | +1487.0% | -251.2% | -50.7% |
| 5 y5 years | +516.4% | -116.3% | -91.1% |
SPRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.0% | 9.75 | +12.3% | |
| 3 m | 3-month | 12.58 | -13.0% | 3.22 | +240.1% |
| 6 m | 6-month | 12.58 | -13.0% | -0.45 | +2533.3% |
| 1 y | 1-year | 12.58 | -13.0% | -0.45 | +2533.3% |
| 3 y | 3-year | 12.58 | -13.0% | -32.17 | +134.0% |
| 5 y | 5-year | 12.58 | -13.0% | -32.17 | +134.0% |
| alltime | all time | 12.58 | -13.0% | -32.17 | +134.0% |
Spero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 10.95(+61.3%) |
| 2024 | 6.79(+3133.3%) |
| 2023 | 0.21(-22.2%) |
| 2022 | 0.27(-105.7%) |
| Date | Value |
|---|---|
| 2021 | -4.74(-25.0%) |
| 2020 | -6.32(+145.9%) |
| 2019 | -2.57(+52.1%) |
| 2018 | -1.69(-16.7%) |
| 2017 | -2.03 |
FAQ
- What is Spero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Spero Therapeutics?
- What is SPRO EV/EBITDA year-to-date change?
- What is Spero Therapeutics EV/EBITDA year-on-year change?
What is Spero Therapeutics EV/EBITDA?
The current EV/EBITDA of SPRO is 10.95
What is the all time high EV/EBITDA for Spero Therapeutics?
Spero Therapeutics all-time high EV/EBITDA is 12.58
What is SPRO EV/EBITDA year-to-date change?
Spero Therapeutics EV/EBITDA has changed by +4.16 (+61.27%) since the beginning of the year
What is Spero Therapeutics EV/EBITDA year-on-year change?
Over the past year, SPRO EV/EBITDA has changed by +10.26 (+1486.96%)